BerandaLSTA • NASDAQ
add
Lisata Therapeutics Inc
$2,16
Setelah Jam Perdagangan Normal:(0,46%)-0,0100
$2,15
Tutup: 16 Jan, 20.00.00 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$2,18
Rentang hari
$2,11 - $2,24
Rentang tahun
$1,81 - $4,11
Kapitalisasi pasar
19,05 jt USD
Volume Rata-Rata
33,73 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 4,41 jt | -17,28% |
Penghasilan bersih | -4,25 jt | 13,81% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,49 | 16,95% |
EBITDA | -4,37 jt | 17,45% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 19,00 jt | -47,02% |
Total aset | 21,76 jt | -43,04% |
Total liabilitas | 4,64 jt | -2,58% |
Total ekuitas | 17,12 jt | — |
Saham yang beredar | 8,82 jt | — |
Harga terhadap nilai buku | 1,10 | — |
Tingkat pengembalian aset | -47,04% | — |
Tingkat pengembalian modal | -58,17% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -4,25 jt | 13,81% |
Kas dari operasi | -3,34 jt | -32,72% |
Kas dari investasi | 5,15 jt | 181,68% |
Kas dari pembiayaan | 353,00 rb | — |
Perubahan kas bersih | 2,16 jt | 124,62% |
Arus kas bebas | -1,84 jt | -115,02% |
Tentang
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Didirikan
1980
Kantor pusat
Situs
Karyawan
26
